Advertisement

Cancer of Other Origin

  • Ben Davidson
  • Claire W. Michael
  • Pınar Fırat
Chapter

Abstract

The list of malignant tumors that may affect the serosal cavities in the form of malignant effusions is essentially as long as the list of existing cancers, as almost any type of malignancy has been described at this anatomic site. There are, however, considerable variations in terms of incidence that must be taken into account. The previous chapters in this section focused on five of the more commonly diagnosed entities in effusion diagnosis – breast, lung, and ovarian carcinomas; malignant mesothelioma; and hematological cancers. The frequency with which one may diagnose any of the remaining cancers depends on the type of institution and diagnostic service one works in, as well as on geographic factors. Nevertheless, the most frequently encountered tumors among those discussed in this chapter are undoubtedly those originating from the gastrointestinal tract, followed by metastases from uterine (endometrial and cervical) carcinomas, with the remaining entities ranging from infrequent to exceedingly rare. It should be noted that papers cited in this chapter are limited to those in which unequivocal presence of tumor cells has been documented in the effusion based on cytological evaluation. Reports in which effusions have been described as “malignant” based on the fact that the patient had documented metastasis to the same anatomic compartment that has been diagnosed in biopsy material have not been included in this discussion.

Keywords

Renal Cell Carcinoma Germ Cell Tumor Signet Ring Cell Clear Cell Carcinoma Malignant Pleural Effusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jiang Y, Ajani JA. Multidisciplinary management of gastric cancer. Curr Opin Gastroenterol. 2010;26:640-646.PubMedCrossRefGoogle Scholar
  2. 2.
    Lee J, Lim T, Uhm JE, et al. Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann Oncol. 2007;18:886-891.PubMedCrossRefGoogle Scholar
  3. 3.
    Kunisaki C, Ishino J, Nakajima S, et al. Outcomes of mass screening for gastric carcinoma. Ann Surg Oncol. 2006;13:221-228.PubMedCrossRefGoogle Scholar
  4. 4.
    Lello E, Furnes B, Edna TH. Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years. Acta Oncol. 2007;46:308-315.PubMedCrossRefGoogle Scholar
  5. 5.
    Oh SY, Kwon HC, Lee S, et al. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites. Jpn J Clin Oncol. 2007;37:930-935.PubMedCrossRefGoogle Scholar
  6. 6.
    Yang XJ, Li Y, Yonemura Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: results from a Chinese center. J Surg Oncol. 2010;101:457-464.PubMedCrossRefGoogle Scholar
  7. 7.
    Kitayama J, Ishigami H, Kaisaki S, et al. Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer. Oncology. 2010;78:40-46.PubMedCrossRefGoogle Scholar
  8. 8.
    Ishigami H, Kitayama J, Kaisaki S, et al. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2010;21:67-70.PubMedCrossRefGoogle Scholar
  9. 9.
    Heiss MM, Murawa P, Koralewski P, et al. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial. Int J Cancer. 2010;127:2209-2221.PubMedCrossRefGoogle Scholar
  10. 10.
    Al-Batran SE, Atmaca A, Schleyer E, et al. Imatinib mesylate for targeting the platelet-derived growth factor beta receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer—a dose-­escalation Phase I trial. Cancer. 2007;109:1897-1904.PubMedCrossRefGoogle Scholar
  11. 11.
    Spieler P, Gloor F. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies. Acta Cytol. 1985;29:753-767.PubMedGoogle Scholar
  12. 12.
    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.PubMedCrossRefGoogle Scholar
  13. 13.
    DeWitt J, Yu M, Al-Haddad MA, Sherman S, McHenry L, Leblanc JK. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA. Gastrointest Endosc. 2010;71:260-265.PubMedCrossRefGoogle Scholar
  14. 14.
    Zervos EE, Osborne D, Boe BA, Luzardo G, Goldin SB, Rosemurgy AS. Prognostic significance of new onset ascites in patients with pancreatic cancer. World J Surg Oncol. 2006;4:16.PubMedCrossRefGoogle Scholar
  15. 15.
    Nakata B, Nishino H, Ogawa Y, et al. Prognostic predictive value of endoscopic ultrasound findings for invasive ductal carcinomas of pancreatic head. Pancreas. 2005;30:200-205.PubMedCrossRefGoogle Scholar
  16. 16.
    Shukuya T, Yasui H, Boku N, et al. Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study. Jpn J Clin Oncol. 2010;40:1135-1138.PubMedCrossRefGoogle Scholar
  17. 17.
    Yonemori K, Okusaka T, Ueno H, Morizane C, Takesako Y, Ikeda M. FP therapy for controlling malignant ascites in advanced pancreatic cancer patients. Hepatogastroenterology. 2007;54:2383-2386.PubMedGoogle Scholar
  18. 18.
    Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg. 1991;161:26-29. Discussion 29–30.PubMedCrossRefGoogle Scholar
  19. 19.
    Lei S, Kini J, Kim K, Howard JM. Pancreatic cancer. Cytologic study of peritoneal washings. Arch Surg. 1994;129:639-642.PubMedCrossRefGoogle Scholar
  20. 20.
    Di Bonito L, Dudine S, Falconieri G. Cytopathology of exocrine pancreatic carcinoma in effusions. Acta Cytol. 1991;35:311-314.PubMedGoogle Scholar
  21. 21.
    DeMay RM, ed. The Art & Science of Cytopathology. Chicago: ASCP Press; 1996:257-325.Google Scholar
  22. 22.
    Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am J Surg Pathol. 1995;19:1390-1408.PubMedCrossRefGoogle Scholar
  23. 23.
    Bradley RF, Stewart JH 4th, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30:551-559.PubMedCrossRefGoogle Scholar
  24. 24.
    Jackson SL, Fleming RA, Loggie BW, Geisinger KR. Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients. Mod Pathol. 2001;14:664-671.PubMedCrossRefGoogle Scholar
  25. 25.
    Wojcik EM, Selvaggi SM. Goblet-cell carcinoid tumor in peritoneal fluid: a case report. Diagn Cytopathol. 1991;7:155-157.PubMedCrossRefGoogle Scholar
  26. 26.
    Kobayashi TK, Ueda M, Nishino T, Tamagaki T, Watanabe S, Kushima R. Malignant pleural effusions due to adeno-endocrine-cell carcinoma of the appendix: a case report. Diagn Cytopathol. 1997;16:522-525.PubMedCrossRefGoogle Scholar
  27. 27.
    Zafar S, Chen H, Sun W, Das K. Cytology of metastatic appendiceal goblet cell carcinoid in pleural effusion fluid: a case report. Diagn Cytopathol. 2008;36:894-898.PubMedCrossRefGoogle Scholar
  28. 28.
    Cameron SE, Alsharif M, McKeon D, Pambuccian SE. Cytology of metastatic thymic well-differentiated neuroendocrine carcinoma (thymic carcinoid) in pleural fluid: report of a case. Diagn Cytopathol. 2008;36:333-337.PubMedCrossRefGoogle Scholar
  29. 29.
    Vasseur B, Cadiot G, Zins M, et al. Peritoneal carcinomatosis in patients with digestive endocrine tumors. Cancer. 1996;78:1686-1692.PubMedCrossRefGoogle Scholar
  30. 30.
    Ikeda M, Okusaka T, Ueno H, et al. Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma. Jpn J Clin Oncol. 2008;38:675-682.PubMedCrossRefGoogle Scholar
  31. 31.
    Carr BI, Pancoska P, Branch RA. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study. Hepatol Int. 2009;4:396-405.PubMedCrossRefGoogle Scholar
  32. 32.
    Thrall MJ, Giampoli EJ. Routine review of ascites fluid from patients with cirrhosis or hepatocellular carcinoma is a low-yield procedure: an observational study. Cytojournal. 2009;6:16.PubMedCrossRefGoogle Scholar
  33. 33.
    Falconieri G, Zanconati F, Colautti I, Dudine S, Bonifacio-Gori D, Di Bonito L. Effusion cytology of hepatocellular carcinoma. Acta Cytol. 1995;39:893-897.PubMedGoogle Scholar
  34. 34.
    Colli A, Cocciolo M, Riva C, et al. Ascitic fluid analysis in hepatocellular carcinoma. Cancer. 1993;72:677-682.PubMedCrossRefGoogle Scholar
  35. 35.
    Morishita Y, Etori F, Sawada K, et al. Sarcomatous hepatocellular carcinoma with malignant ascites. A report of two cases. Acta Cytol. 1998;42:759-764.PubMedCrossRefGoogle Scholar
  36. 36.
    Swisher SG, Rice DC, Ajani JA, Komaki RK, Ferguson MK. Neoplasms of the esophagus. In: Kufe DW, Bast Jr RC, Hait WM, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E III, eds. Cancer Medicine. 7th ed. Chap 85. Hamilton: BC Decker Inc; 2006:1255-1267.Google Scholar
  37. 37.
    Ozyurtkan MO, Balci AE, Cakmak M. Predictors of mortality within three months in the patients with malignant pleural effusion. Eur J Intern Med. 2010;21:30-34.PubMedCrossRefGoogle Scholar
  38. 38.
    Renshaw AA, Nappi D, Sugarbaker DJ, Swanson S. Effusion cytology of esophageal carcinoma. Cancer. 1997;81:365-372.PubMedCrossRefGoogle Scholar
  39. 39.
    Gamez RG, Jessurun J, Berger MJ, Pambuccian SE. Cytology of metastatic cervical squamous cell carcinoma in pleural fluid: report of a case confirmed by human papillomavirus typing. Diagn Cytopathol. 2009;37:381-387.PubMedCrossRefGoogle Scholar
  40. 40.
    Semczuk A, Skomra D, Rybojad P, Jeczen´ R, Rechberger T. Endometrial carcinoma with pleural metastasis: a case report. Acta Cytol. 2006;50:697-700.PubMedCrossRefGoogle Scholar
  41. 41.
    Kogan J, Golzman B, Turkot S, Ben-Dor D, Charkowsky T, Oren S. Malignant pericardial effusion and cardiac tamponade as a late complication of endometrial carcinoma. Eur J Intern Med. 2004;15:318-320.PubMedCrossRefGoogle Scholar
  42. 42.
    Jamshed A, Khafaga Y, El-Husseiny G, Gray AJ, Manji M. Pericardial metastasis in carcinoma of the uterine cervix. Gynecol Oncol. 1996;61:451-453.PubMedCrossRefGoogle Scholar
  43. 43.
    Santala M, Puistola U, Kauppila A. Endometrial adenocarcinoma complicated by malignant pericardial effusion. Gynecol Oncol. 1995;56:444-445.PubMedCrossRefGoogle Scholar
  44. 44.
    Rieke JW, Kapp DS. Successful management of malignant pericardial effusion in metastatic squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1988;31:338-351.PubMedCrossRefGoogle Scholar
  45. 45.
    Hayashi Y, Iwasaka T, Hachisuga T, Kishikawa T, Ikeda N, Sugimori H. Malignant pericardial effusion in endometrial adenocarcinoma. Gynecol Oncol. 1988;29:234-239.PubMedCrossRefGoogle Scholar
  46. 46.
    Silver SA, Devouassoux-Shisheboran M, Mezzetti TP, Tavassoli FA. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings. Am J Surg Pathol. 2001;25:379-387.PubMedCrossRefGoogle Scholar
  47. 47.
    Khunamornpong S, Siriaunkgul S, Suprasert P. Cytology of small-cell carcinoma of the uterine cervix in serous effusion: a report on two cases. Diagn Cytopathol. 2001;24:253-255.PubMedCrossRefGoogle Scholar
  48. 48.
    Atahan S, Ekinci C, Içli F, Erdoğan N. Cytology of clear cell carcinoma of the female genital tract in fine needle aspirates and ascites. Acta Cytol. 2000;44:1005-1009.PubMedCrossRefGoogle Scholar
  49. 49.
    Zhou C, Gilks CB, Hayes M, Clement PB. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol. 1998;22:113-120.PubMedCrossRefGoogle Scholar
  50. 50.
    Johnston WW. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer. 1985;56:905-909.PubMedCrossRefGoogle Scholar
  51. 51.
    McGrath SM, Rana DN, Lynch M, Desai M. Metastatic transitional cell carcinoma causing a unilateral pleural effusion: a case report. Acta Cytol. 2008;52:351-353.PubMedCrossRefGoogle Scholar
  52. 52.
    Renshaw AA, Madge R, Granter SR. Intracytoplasmic eosinophilic inclusions (Melamed-Wolinska bodies). Association with metastatic transitional cell carcinoma in pleural fluid. Acta Cytol. 1997;41:995-998.PubMedCrossRefGoogle Scholar
  53. 53.
    Fabozzi SJ, Newton JR Jr, Moriarty RP, Schellhammer PF. Malignant pericardial effusion as initial solitary site of metastasis from transitional cell carcinoma of the bladder. Urology. 1995;45:320-322.PubMedCrossRefGoogle Scholar
  54. 54.
    Xiao GQ. Cytomorphology of urothelial carcinomatous peritoneal effusion. Cytopathology. 2008;19:131-133.PubMedCrossRefGoogle Scholar
  55. 55.
    Kim SS, Choi YD, Nam JH, Kwon DD, Juhng SW, Choi C. Cytologic features of primary signet ring cell carcinoma of the bladder: a case report. Acta Cytol. 2009;53:309-312.PubMedCrossRefGoogle Scholar
  56. 56.
    Cimino-Mathews A, Ali SZ. Metastatic urothelial carcinoma with signet ring features: cytomorphologic findings in abdominal paracentesis. Diagn Cytopathol. 2011;39:132-134.PubMedCrossRefGoogle Scholar
  57. 57.
    Islam N, Ahmedani MY. Renal carcinoma presenting as cardiac tamponade: a case report and review of literature. Int J Cardiol. 1998;64:207-211.PubMedCrossRefGoogle Scholar
  58. 58.
    Mai KT, Roustan Delatour NL, Assiri A, Al-Maghrabi H. Secondary prostatic adenocarcinoma: a cytopathological study of 50 cases. Diagn Cytopathol. 2007;35:91-95.PubMedCrossRefGoogle Scholar
  59. 59.
    Renshaw AA, Nappi D, Cibas ES. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions. Diagn Cytopathol. 1996;15:103-107.PubMedCrossRefGoogle Scholar
  60. 60.
    Saif MW, Figg WD, Hewitt S, Brosky K, Reed E, Dahut W. Malignant ascites as only manifestation of metastatic prostate cancer. Prostate Cancer Prostatic Dis. 1999;2:290-293.PubMedCrossRefGoogle Scholar
  61. 61.
    Saif MW. Malignant ascites associated with carcinoma of the prostate. J Appl Res. 2005;5:305-311.PubMedGoogle Scholar
  62. 62.
    Catton PA, Hartwick RW, Srigley JR. Prostate cancer presenting with malignant ascites: signet-ring cell variant of prostatic adenocarcinoma. Urology. 1992;39:495-497.PubMedCrossRefGoogle Scholar
  63. 63.
    Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol. 1987;31:85-97.PubMedGoogle Scholar
  64. 64.
    Renshaw AA, Comiter CV, Nappi D, Granter SR. Effusion cytology of renal cell carcinoma. Cancer. 1998;84:148-152.PubMedCrossRefGoogle Scholar
  65. 65.
    Gupta R, Mathur SR, Iyer VK, Kumar AS, Seth A. Cytomorphologic consideration in malignant ascites with renal cell carcinoma: a report of two cases. Cytojournal. 2010;7:4.PubMedCrossRefGoogle Scholar
  66. 66.
    Chute DJ, Kong CS, Stelow EB. Immunohistochemistry for the detection of renal cell carcinoma in effusion cytology. Diagn Cytopathol. 2011;39:118-123.PubMedCrossRefGoogle Scholar
  67. 67.
    Knoepp SM, Kunju LP, Roh MH. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Diagn Cytopathol. 2010 Dec 31 [Epub ahead if print].Google Scholar
  68. 68.
    Teresa P, Maria Grazia Z, Doriana M, Irene P, Michele S. Malignant effusion of chromophobe renal-cell carcinoma: cytological and immunohistochemical findings. Diagn Cytopathol. 2011 Jan 6 [Epub ahead if print].Google Scholar
  69. 69.
    Ellis CL, Burroughs F, Michael CW, Li QK. Cytology of metastatic renal medullary carcinoma in pleural effusion: a study of two cases. Diagn Cytopathol. 2009;37:843-848.PubMedCrossRefGoogle Scholar
  70. 70.
    Caraway NP, Wojcik EM, Katz RL, Ro JY, Ordóñez NG. Cytologic findings of collecting duct carcinoma of the kidney. Diagn Cytopathol. 1995;13:304-309.PubMedCrossRefGoogle Scholar
  71. 71.
    Drut R. Malignant rhabdoid tumor of the kidney diagnosed by fine-needle aspiration cytology. Diagn Cytopathol. 1990;6:124-126.PubMedCrossRefGoogle Scholar
  72. 72.
    Hajdu SI, Nolan MA. Exfoliative cytology of malignant germ cell tumors. Acta Cytol. 1975;19:255-260.PubMedGoogle Scholar
  73. 73.
    Geisinger KR, Hajdu SI, Helson L. Exfoliative cytology of nonlymphoreticular neoplasms in children. Acta Cytol. 1984;28:16-28.PubMedGoogle Scholar
  74. 74.
    Wong JW, Pitlik D, Abdul-Karim FW. Cytology of pleural, peritoneal and pericardial fluids in children. A 40-year summary. Acta Cytol. 1997;41:467-473.PubMedCrossRefGoogle Scholar
  75. 75.
    Kashimura M, Tsukamoto N, Matsuyama T, Kashimura Y, Sugimori H, Taki I. Cytologic findings of ascites from patients with ovarian dysgerminoma. Acta Cytol. 1983;27:59-62.PubMedGoogle Scholar
  76. 76.
    Roncalli M, Gribaudi G, Simoncelli D, Servida E. Cytology of yolk-sac tumor of the ovary in ascitic fluid. Report of a case. Acta Cytol. 1988;32:113-116.PubMedGoogle Scholar
  77. 77.
    Selvaggi SM. Cytologic features of malignant ovarian monodermal teratoma with an ependymal component in peritoneal washings. Int J Gynecol Pathol. 1992;11:299-303.PubMedCrossRefGoogle Scholar
  78. 78.
    Valente PT, Schantz HD, Edmonds PR, Hanjani P. Peritoneal cytology of uncommon ovarian tumors. Diagn Cytopathol. 1992;8:98-106.PubMedCrossRefGoogle Scholar
  79. 79.
    Selvaggi SM, Guidos BJ. Immature teratoma of the ovary on fluid cytology. Diagn Cytopathol. 2001;25:411-414.PubMedCrossRefGoogle Scholar
  80. 80.
    Abe T, Shinohara N, Harabayashi T, et al. Peritoneal carcinomatosis in refractory seminoma. Int J Urol. 2004;11:184-186.PubMedCrossRefGoogle Scholar
  81. 81.
    Ikeda K, Tate G, Suzuki T, Mitsuya T. Cytomorphologic features of immature ovarian teratoma in peritoneal effusion: a case report. Diagn Cytopathol. 2005;33:39-42.PubMedCrossRefGoogle Scholar
  82. 82.
    Murugan P, Siddaraju N, Sridhar E, Soundararaghavan J, Habeebullah S. Unusual ovarian malignancies in ascitic fluid: a report of 2 cases. Acta Cytol. 2010;54:611-617.PubMedGoogle Scholar
  83. 83.
    Izban KF, Candel AG, Hsi ED, Selvaggi SM. Metastatic melanoma of the vulva identified by peritoneal fluid cytology. Diagn Cytopathol. 1999;20:152-155.PubMedCrossRefGoogle Scholar
  84. 84.
    Longatto Filho A, de Carvalho LV, Santos Gda C, et al. Cytologic diagnosis of melanoma in serous effusions. A morphologic and immunocytochemical study. Acta Cytol. 1995;39:481-484.PubMedGoogle Scholar
  85. 85.
    Beaty MW, Fetsch P, Wilder AM, Marincola F, Abati A. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody. Cancer. 1997;81:57-63.PubMedCrossRefGoogle Scholar
  86. 86.
    Ikeda K, Tate G, Iezumi K, Suzuki T, Kitamura T, Mitsuya T. Effusion cytomorphology and immunocytochemistry of malignant melanoma: five cases of melanotic melanoma and one case of amelanotic melanoma. Diagn Cytopathol. 2009;37:516-521.PubMedCrossRefGoogle Scholar
  87. 87.
    Niemann TH, Thomas PA. Melanoma with signet-ring cells in a peritoneal effusion. Diagn Cytopathol. 1995;12:241-244.PubMedCrossRefGoogle Scholar
  88. 88.
    Pinto MM. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Use as a marker for melanoma. Acta Cytol. 1986;30:240-244.PubMedGoogle Scholar
  89. 89.
    Cohen I, Loberant N, King E, Herskovits M, Sweed Y, Jerushalmi J. Rhabdomyosarcoma in a child with massive pleural effusion: cytological diagnosis from pleural fluid. Diagn Cytopathol. 1999;21:125-128.PubMedCrossRefGoogle Scholar
  90. 90.
    Abadi MA, Zakowski MF. Cytologic features of sarcomas in fluids. Cancer. 1998;84:71-76.PubMedCrossRefGoogle Scholar
  91. 91.
    Longatto-Filho A, Bisi H, Bortolan J, Granja NV, Lombardo V. Cytologic diagnosis of metastatic sarcoma in effusions. Acta Cytol. 2003;47:317-318.PubMedGoogle Scholar
  92. 92.
    Allsbrook WC Jr, Stead NW, Pantazis CG, Houston JH, Crosby JH. Embryonal rhabdomyosarcoma in ascitic fluid. Immunocytochemical and DNA flow cytometric study. Arch Pathol Lab Med. 1986;110:847-849.PubMedGoogle Scholar
  93. 93.
    Thompson KS, Jensen JD, Bhoopalam N, Reyes CV. Pleural effusion cytology of embryonal rhabdomyosarcoma. Diagn Cytopathol. 1997;16:270-273.PubMedCrossRefGoogle Scholar
  94. 94.
    Cribbs RK, Shehata BM, Ricketts RR. Primary ovarian rhabdomyosarcoma in children. Pediatr Surg Int. 2008;24:593-595.PubMedCrossRefGoogle Scholar
  95. 95.
    Yao JC, Wang WC, Tseng HH, Hwang WS. Primary rhabdomyosarcoma of the prostate. Diagnosis by needle biopsy and immunocytochemistry. Acta Cytol. 1988;32:509-512.PubMedGoogle Scholar
  96. 96.
    Ohi S. Characterization, anticancer drug susceptibility and atRA-induced growth inhibition of a novel cell line (HUMEMS) established from pleural effusion of alveolar rhabdomyosarcoma of breast tissue. Hum Cell. 2007;20:39-51.PubMedCrossRefGoogle Scholar
  97. 97.
    Kaw YT, Cramer HM. Cytologic diagnosis of rhabdomyosarcoma in a patient with germ cell tumor. A case report. Acta Cytol. 1995;39:249-251.PubMedGoogle Scholar
  98. 98.
    Bhattacharya B, Sariya D, Reddy VB, Kluskens L, Gould VE, Gattuso P. Application of adjunct techniques in cytologic material in the diagnosis of rhabdomyosarcoma: case report and review of the literature. Diagn Cytopathol. 2002;26:384-386.PubMedCrossRefGoogle Scholar
  99. 99.
    Thiryayi SA, Rana DN, Roulson J, et al. Diagnosis of alveolar rhabdomyosarcoma in effusion cytology: a diagnostic pitfall. Cytopathology. 2010;21:273-275.PubMedCrossRefGoogle Scholar
  100. 100.
    Theunissen P, Cremers M, van der Meer S, Bot F, Bras J. Cytologic diagnosis of rhabdomyosarcoma in a child with a pleural effusion. A case report. Acta Cytol. 2004;48:249-253.PubMedCrossRefGoogle Scholar
  101. 101.
    Yuregir OO, Sahin FI, Avci Z, Yilmaz Z, Celasun B, Sarialioglu F. Multiple chromosome abnormalities in the pleural fluid of a patient with recurrent Ewing sarcoma. Pediatr Hematol Oncol. 2009;26:267-272.PubMedCrossRefGoogle Scholar
  102. 102.
    Schiavo R, Tullio C, La Grotteria M, et al. Establishment and characterization of a new Ewing’s sarcoma cell line from a malignant pleural effusion. Anticancer Res. 2007;27:3273-3278.PubMedGoogle Scholar
  103. 103.
    Nishio J, Iwasaki H, Ishiguro M, et al. Establishment and characterization of a novel human desmoplastic small round cell tumor cell line, JN-DSRCT-1. Lab Invest. 2002;82:1175-1182.PubMedGoogle Scholar
  104. 104.
    Hallman JR, Geisinger KR. Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey. Acta Cytol. 1994;38:209-217.PubMedGoogle Scholar
  105. 105.
    Berry GJ, Anderson CJ, Pitts WC, Neitzel GF, Weiss LM. Cytology of angiosarcoma in effusions. Acta Cytol. 1991;35:538-542.PubMedGoogle Scholar
  106. 106.
    Boucher LD, Swanson PE, Stanley MW, Silverman JF, Raab SS, Geisinger KR. Cytology of angiosarcoma. Findings in fourteen fine-needle aspiration biopsy specimens and one pleural fluid specimen. Am J Clin Pathol. 2000;114:210-219.PubMedCrossRefGoogle Scholar
  107. 107.
    Davidson B, Abeler VM. Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature. Diagn Cytopathol. 2005;32:307-309.PubMedCrossRefGoogle Scholar
  108. 108.
    Antic T, Staerkel G. Mediastinal epithelioid hemangioendothelioma metastatic to lymph nodes and pleural fluid: report of a case. Diagn Cytopathol. 2010;38:113-116.PubMedGoogle Scholar
  109. 109.
    Buggage RR, Soudi N, Olson JL, Busseniers AE. Epithelioid hemangioendothelioma of the lung: pleural effusion cytology, ultrastructure, and brief literature review. Diagn Cytopathol. 1995;13:54-60.PubMedCrossRefGoogle Scholar
  110. 110.
    Geisinger KR, Naylor B, Beals TF, Novak PM. Cytopathology, including transmission and scanning electron microscopy, of pleomorphic liposarcomas in pleural fluids. Acta Cytol. 1980;24:435-441.PubMedGoogle Scholar
  111. 111.
    Kudo N, Ogose A, Hotta T, et al. Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation. Virchows Arch. 2007;451:691-699.PubMedCrossRefGoogle Scholar
  112. 112.
    Ikemoto S, Sugimura K, Yoshida N, Nakatani T. Chondrosarcoma of the urinary bladder and establishment of a human chondrosarcoma cell line (OCUU-6). Hum Cell. 2004;17:93-96.Google Scholar
  113. 113.
    Chen KT. Effusion cytology of metastatic extraskeletal myxoid chondrosarcoma. Diagn Cytopathol. 2003;28:222-223.PubMedCrossRefGoogle Scholar
  114. 114.
    Ng WK, Lui PC, Ma L. Peritoneal washing cytology findings of disseminated myxoid leiomyosarcoma of uterus: report of a case with emphasis on possible differential diagnosis. Diagn Cytopathol. 2002;27:47-52.PubMedCrossRefGoogle Scholar
  115. 115.
    Tsuchido K, Yamada M, Satou T, Otsuki Y, Shimizu S, Kobayashi H. Cytology of sclerosing epithelioid fibrosarcoma in pleural effusion. Diagn Cytopathol. 2010;38:748-753.PubMedGoogle Scholar
  116. 116.
    Nguyen GK, Jeannot A. Cytology of synovial sarcoma metastases in pleural fluid. Acta Cytol. 1982;26:517-520.PubMedGoogle Scholar
  117. 117.
    Sonobe H, Manabe Y, Furihata M, et al. Establishment and characterization of a new human synovial sarcoma cell line, HS-SY-II. Lab Invest. 1992;67:498-505.PubMedGoogle Scholar
  118. 118.
    Awasthi A, Gupta N, Srinivasan R, Nijhawan R, Rajwanshi A. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India. Cytopathology. 2007;18:28-32.PubMedCrossRefGoogle Scholar
  119. 119.
    Knapik J, Yachnis AT, Ripley D, et al. Aggressive uterine sarcoma with rhabdoid features: diagnosis by peritoneal fluid cytology and absence of INI1 gene mutation. Hum Pathol. 2001;32:884-886.PubMedCrossRefGoogle Scholar
  120. 120.
    Hirakawa E, Kobayashi S, Miki H, et al. Ascitic fluid cytology of adenosarcoma of the ovary: a case report. Diagn Cytopathol. 2001;24:343-346.PubMedCrossRefGoogle Scholar
  121. 121.
    Keller JM, Listrom MB, Hart JB, Olson NJ, Jordan SW. Cytologic detection of penile malignant melanoma of soft parts in pleural effusion using monoclonal antibody HMB-45. Acta Cytol. 1990;34:393-396.PubMedGoogle Scholar
  122. 122.
    Jaffer S, Woodruff JM. Cytology of melanotic schwannoma in a fine needle aspirate and pleural fluid. A case report. Acta Cytol. 2000;44:1095-1100.PubMedCrossRefGoogle Scholar
  123. 123.
    Motoyama T, Watanabe H. Ascitic fluid cytologic features of a malignant mixed mesodermal tumor of the ovary. Acta Cytol. 1987;31:63-67.PubMedGoogle Scholar
  124. 124.
    Farr GH, Hajdu SI. Exfoliative cytology of metastatic neuroblastoma. Acta Cytol. 1972;16:203-206.PubMedGoogle Scholar
  125. 125.
    Baliga M, Holmquist N, Warrier RP. Alteration of Wilms’ tumor staging by cytologic detection of malignant cells in chylous ascites. Diagn Cytopathol. 1995;12:357-359.PubMedCrossRefGoogle Scholar
  126. 126.
    Vernon AN, Sheeler LR, Biscotti CV, Stoller JK. Pleural effusion resulting from metastatic papillary carcinoma of the thyroid. Chest. 1992;101:1448-1450.PubMedCrossRefGoogle Scholar
  127. 127.
    Vassilopoulou-Sellin R, Sneige N. Pleural effusion in patients with differentiated papillary thyroid cancer. South Med J. 1994;87:1111-1116.PubMedCrossRefGoogle Scholar
  128. 128.
    Hyman MP. Papillary and undifferentiated thyroid carcinoma presenting as a metastatic papillary serous effusion. A case report. Acta Cytol. 1979;23:483-486.PubMedGoogle Scholar
  129. 129.
    Siddaraju N, Viswanathan VK, Saka VK, Basu D, Shanmugham C. Fine needle aspiration of follicular variant of papillary thyroid carcinoma presenting with pleural effusion: a case report. Acta Cytol. 2007;51:911-915.PubMedCrossRefGoogle Scholar
  130. 130.
    Hsu KF, Hsieh CB, Duh QY, Chien CF, Li HS, Shih ML. Hürthle cell carcinoma of the thyroid with contralateral malignant pleural effusion. Onkologie. 2009;32:47-49.PubMedCrossRefGoogle Scholar
  131. 131.
    Geisinger KR, Steffee CH, McGee RS, Woodruff RD, Buss DH. The cytomorphologic features of sclerosing mucoepidermoid carcinoma of the thyroid gland with eosinophilia. Am J Clin Pathol. 1998;109:294-301.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  • Ben Davidson
    • 1
  • Claire W. Michael
    • 2
  • Pınar Fırat
    • 3
  1. 1.Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, The Medical FacultyUniversity of OsloOsloNorway
  2. 2.Department of PathologyThe University of MichiganAnn ArborUSA
  3. 3.Department of Pathology, İstanbul Faculty of Medicineİstanbul UniversityİstanbulTurkey

Personalised recommendations